Novo Nordisk (NYSE:NVO) is one of the most profitable value stocks to buy according to analysts. On July 25, Novo Nordisk announced that the European Medicines Agency’s Committee for Medicinal ...
SAN RAFAEL, Calif., Feb. 2, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that the Company will be presenting data in several presentations on valoctocogene ...
Novo Nordisk's Alhemo drug has been recommended for European approval as a treatment for hemophilia, the company said Friday. The Danish pharmaceutical giant said European regulators have recommended ...